BRIAN K LINK, MD
Osteopathic Medicine at Hawkins Dr, Iowa City, IA

License number
Iowa 27613
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Iowa 27613
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 353-8504
(319) 353-8383 (Fax)

Organization information

See more information about BRIAN K LINK at bizstanding.com

University Of Iowa Hosps CLNCS - Brian K Link MD

200 Hawkins Dr #C606, Iowa City, IA 52242

Categories:
Internal Medicine Physicians & Surgeons
Phone:
(319) 356-1616 (Phone)

Professional information

Brian K Link Photo 1

Dr. Brian K Link, Iowa City IA - MD (Doctor of Medicine)

Specialties:
Hematology, Medical Oncology, Oncology
Address:
UNIVERSITY OF IOWA HOSP MEDICINE SPECIALTIES CLINIC
200 Hawkins Dr, Iowa City 52242
(319) 356-1616 (Phone), (319) 356-7893 (Fax)
University Of Iowa Mdcn Spec Cl
200 Hawkins Dr, Iowa City 52242
(319) 356-8133 (Phone)
Certifications:
Hematology, 2006, Internal Medicine, 1989, Medical Oncology, 2006
Awards:
Healthgrades Honor Roll
Languages:
English, German
Hospitals:
UNIVERSITY OF IOWA HOSP MEDICINE SPECIALTIES CLINIC
200 Hawkins Dr, Iowa City 52242
University Of Iowa Mdcn Spec Cl
200 Hawkins Dr, Iowa City 52242
Mercy Iowa City
500 East Market St, Iowa City 52245
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
University of Ia Roy J & L Carver Com
Graduated: 1986
Rush Presby-St Lukes Med Ct


Brian K Link Photo 2

Brian K Link, Iowa City IA

Specialties:
Internist
Address:
200 Hawkins Dr, Iowa City, IA 52242
Education:
University of Iowa, Roy J. and Lucille A. Carver College of Medicine - Doctor of Medicine
Rush University Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Brian K Link Photo 3

Brian K Link, Iowa City IA

Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology
Work:
University Of Iowa Hospital & Clinic
200 Hawkins Dr, Iowa City, IA 52243 Cancer Care Of Iowa City
613 E Bloomington St, Iowa City, IA 52245
Education:
University of Iowa (1986)


Brian Link Photo 4

Humanized Antibodies Against Cd3

US Patent:
2008002, Jan 31, 2008
Filed:
Mar 26, 2007
Appl. No.:
11/691350
Inventors:
George Weiner - Iowa City IA, US
Roger Gingrich - Iowa City IA, US
Brian Link - Coralville IA, US
J. Tso - Menlo Park CA, US
Assignee:
Protein Design Labs, Inc. - Fremont CA
Iowa Immunotherapy Investigators - Iowa City IA
International Classification:
A61K 39/395, A61P 31/00, C07K 16/00
US Classification:
424133100, 530387300
Abstract:
The invention provides bispecific antibodies with selective cytotoxicity against malignant B-cells. The bispecific antibodies bind to an effector cell antigen and to a 28/32 kDa heterodimeric protein on the surface of malignant B-cells. The invention also includes the monospecific components of the bispecific antibodies, humanized versions thereof, and humanized bispecific antibodies. The invention further provides therapeutic and diagnostic methods employing these antibodies.


Brian Link Photo 5

Humanized Antibodies Against Cd3

US Patent:
7381803, Jun 3, 2008
Filed:
Jul 18, 2000
Appl. No.:
09/618380
Inventors:
George Weiner - Iowa City IA, US
Roger Gingrich - Iowa City IA, US
Brian K. Link - Coralville IA, US
J. Yun Tso - Menlo Park CA, US
Assignee:
PDL BioPharma, Inc. - Redwood City CA
Iowa Immunotherapy Investigators - Iowa City IA
International Classification:
C07K 16/30
US Classification:
53038885, 5303871, 5303873, 4241331
Abstract:
The invention provides bispecific antibodies with selective cytotoxicity against malignant B-cells. The bispecific antibodies bind to an effector cell antigen and to a 28/32 kDa heterodimeric protein on the surface of malignant B-cells. The invention also includes the monospecific components of the bispecific antibodies, humanized versions thereof, and humanized bispecific antibodies. The invention further provides therapeutic and diagnostic methods employing these antibodies.